Trial · NCT04854707
Results by group25
Each measurement the trial posted, group by group, in the words and numbers it posted.
1 to 20 of 25
Download this page as JSON| Outcome | Group | Category | Value | Spread | Units |
|---|---|---|---|---|---|
| Number of Oocytes Retrieved | Mixed Protocols: Recombinant and Urinary-derived Gonadotropins and Antagonists/Agonists of GnRH | 8.6 | Standard Deviation 6.8 | The total number of retrieved oocytes | |
| Number of Oocytes Retrieved | Monoprotocols: Follitropin Alpha Biosimilar Only and Antagonists/Agonists of GnRH | 10.3 | Standard Deviation 7.4 | The total number of retrieved oocytes | |
| Number of Oocytes Retrieved | Monoprotocols: Follitropin Alpha Biosimilar Only and Antagonists of GnRH | 10.5 | Standard Deviation 7.5 | The total number of retrieved oocytes | |
| Number of Oocytes Retrieved | Monoprotocols: Follitropin Alpha Biosimilar Only and Agonist of GnRH | 9.6 | Standard Deviation 7.0 | The total number of retrieved oocytes | |
| Number of Oocytes Retrieved | The Overall Protocols | 9.5 | Standard Deviation 7.2 | The total number of retrieved oocytes | |
| Percentage of Participants With Ongoing Clinical Pregnancy Per Embryo Transfer | Mixed Protocols: Recombinant and Urinary-derived Gonadotropins and Antagonists/Agonists of GnRH | 39.3 | 95% Confidence Interval 36.9 to 41.7 | Percetnage of patients (%) | |
| Percentage of Participants With Ongoing Clinical Pregnancy Per Embryo Transfer | Monoprotocols: Follitropin Alpha Biosimilar Only and Antagonists/Agonists of GnRH | 37.6 | 95% Confidence Interval 35.3 to 39.8 | Percetnage of patients (%) | |
| Percentage of Participants With Ongoing Clinical Pregnancy Per Embryo Transfer | Monoprotocols: Follitropin Alpha Biosimilar Only and Antagonists of GnRH | 37.9 | 95% Confidence Interval 35.5 to 40.5 | Percetnage of patients (%) | |
| Percentage of Participants With Ongoing Clinical Pregnancy Per Embryo Transfer | Monoprotocols: Follitropin Alpha Biosimilar Only and Agonist of GnRH | 35.9 | 95% Confidence Interval 30.8 to 41.1 | Percetnage of patients (%) | |
| Percentage of Participants With Ongoing Clinical Pregnancy Per Embryo Transfer | The Overall Protocols | 38.4 | 95% Confidence Interval 35.9 to 40.2 | Percetnage of patients (%) | |
| Number of Mature Oocytes | Mixed Protocols: Recombinant and Urinary-derived Gonadotropins and Antagonists/Agonists of GnRH | 6.7 | Standard Deviation 6.2 | Number of mature oocytes | |
| Number of Mature Oocytes | Monoprotocols: Follitropin Alpha Biosimilar Only and Antagonists/Agonists of GnRH | 7.7 | Standard Deviation 6.9 | Number of mature oocytes | |
| Number of Mature Oocytes | Monoprotocols: Follitropin Alpha Biosimilar Only and Antagonists of GnRH | 7.6 | Standard Deviation 6.9 | Number of mature oocytes | |
| Number of Mature Oocytes | Monoprotocols: Follitropin Alpha Biosimilar Only and Agonist of GnRH | 6.7 | Standard Deviation 5.7 | Number of mature oocytes | |
| Number of Mature Oocytes | The Overall Protocols | 6.8 | Standard Deviation 6.6 | Number of mature oocytes | |
| Number of Fertilized Oocytes | Mixed Protocols: Recombinant and Urinary-derived Gonadotropins and Antagonists/Agonists of GnRH | 5.8 | Standard Deviation 5.2 | zygotes with 2PN | |
| Number of Fertilized Oocytes | Monoprotocols: Follitropin Alpha Biosimilar Only and Antagonists/Agonists of GnRH | 7.2 | Standard Deviation 6.2 | zygotes with 2PN | |
| Number of Fertilized Oocytes | Monoprotocols: Follitropin Alpha Biosimilar Only and Antagonists of GnRH | 7.3 | Standard Deviation 6.3 | zygotes with 2PN | |
| Number of Fertilized Oocytes | Monoprotocols: Follitropin Alpha Biosimilar Only and Agonist of GnRH | 5.7 | Standard Deviation 5.0 | zygotes with 2PN | |
| Number of Fertilized Oocytes | The Overall Protocols | 6.1 | Standard Deviation 5.8 | zygotes with 2PN |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT04854707/results